Funding Opportunities
Current CPRIT Funding Opportunities
- Complete descriptions of all current funding opportunities can be found on the CPRIT Funding Opportunities webpage.
- Join the CPRIT mailing list to directly receive announcements and notifications.
- CPRIT Application Receipt System
- Summaries of Prevention, Research, and Commercialization funding opportunities are listed below.
- For additional information, see the CPRIT Policies and Procedures Guide on their Statute, Rules and Grant Policies Guide webpage.
Upcoming Deadlines
- Company Commercialization Awards - August 25, 2011
- Company Formation Awards - August 25, 2011
- Company Relocation Awards - due August 25, 2011
- Texas Life Science Incubator Infrastructure Awards - due August 30, 2011
- Evidence-Based Cancer Prevention Series - due September 16, 2011
- Shared Instrumentation Awards - due November 22, 2011
- Bridging the Gap: Early Translational Research Awards - due November 22, 2011
- Recruitment of Clinical Investigators - due date: continuous
- Recruitment of Established Investigators - due date: continuous
- Recruitment of First-Time, Tenure-Track Faculty Members - due date: continuous
- Recruitment of Missing Links - due date: continuous
- Recruitment of Rising Stars - due date: continuous
Prevention Programs
Evidence-Based Cancer Prevention Series
RFA Release: June 9, 2011
Application Due Date: September 16, 2011
Award Notification: January 2012
This RFA solicits grant applications from qualified organizations located in the State of Texas that propose to deliver evidence-based services in at least one of the following cancer prevention and control areas: 1) Primary cancer prevention (e.g. vaccine-conferred immunity, healthy diet, avoidance of alcohol misuse, physical activity, sun protection); 2) Secondary prevention (e.g., screening/early detection for breast, cervical, and/or colorectal cancer); or 3) Tertiary prevention (e.g., survivorship services such as physical rehabilitation/therapy, psychosocial interventions, navigation services, palliative care). Comprehensive projects that include a continuum of services comprised of all or some of the following are preferred: Public and/or professional education and training, patient support of behavior modification, outreach, delivery of prevention and screening services, follow-up navigation, and survivorship services.
RFA Release: December 3, 2010
Application Due Date: March 22, 2011
Award Notification: July 2011
For programs in the area of A) tobacco prevention and control or B) increasing delivery of primary preventive services for all cancers and screening services for breast, cervical and colorectal cancers.
Evidence-Based Cancer PRevention Series
RFA Release: December 3, 2010
Application Due Date: March 22, 2011
Award Notification: July 2011
For programs to deliver evidence-based services in at least one of the following cancer prevention and control areas: 1) Primary cancer prevention (e.g. vaccine-conferred immunity, healthy diet, avoidance of alcohol misuse, physical activity, sun protection); 2) Secondary prevention (e.g., screening/early detection for breast, cervical, and/or colorectal cancer); or 3) Tertiary prevention (e.g., survivorship services such as physical rehabilitation/therapy, psychosocial interventions, navigation services, palliative care).
Health Behavior Change Through Public and Professional Education and Training
RFA Release: December 3, 2010
Application Due Date: March 22, 2011
Award Notification: July 2011
For health care professional education and training and/or health promotion, education, and outreach for prevention, early detection, and survivorship of cancer for the public that, if successful, would improve the practice and performance of health care practitioners and increase the number of persons who improve their health behaviors related to the prevention of cancer, obtain recommended cancer screening tests, have cancers detected at earlier stages, and improve their quality of life if they are survivors of cancer.
Research Programs
RFA Release: July 7, 2011
Application Due Date: November 22, 2011 (Limited Submission Opportunity)
Award Notification: March 2012
Shared Instrumentation Awards supports the acquisition of major research instrumentation that cannot be requested through other CPRIT programs and whose purchase can be justified on a shared-use basis to support the goals of scientifically meritorious cancer research projects. Award: Up to $3,000,000 in total costs for the first year; up to $300,000 per year for years 2-5.
Bridging the Gap: Early Translational Research Awards
RFA Release: June 16, 2011
Application Due Date: November 22, 2011 (Limited Submission Opportunity)
Award Notification: March 2012
Supports projects that “bridge the gap” between promising new discoveries achieved in the research laboratory and commercial development for a therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario. Award: Up to $1,000,000 in total costs over a period of 1-3 years. Exceptions permitted if extremely well justified.
Recruitment of Clinical Investigators
RFA Release: February 17, 2011
Application Due Date: Continuous
Award Notification: Continuous
Supports investigators performing clinical research who will be or are making strong contributions to clinical cancer research. Candidates for this award may be at various stages of their career: newly independent investigators, rising stars, and established investigators.
Applications must be submitted by the president, provost, or appropriate dean of a Texas-based institution of higher education on behalf of a specific candidate.
Awards of $1 million, $2.5 million, or $5 million total costs for newly independent investigators, rising stars, or established investigators, respectively, will be awarded over 5 years.
Individual Investigator Research Awards
RFA Release: February 15, 2011
Application Due Date: May 31, 2011
Award Notification: October 2011
This RFA solicits applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. CPRIT encourages applications that seek to apply or develop state-of-the-art technologies, tools, and/or resources for cancer research, including those with potential commercialization opportunities. CPRIT will look with special favor on new approaches to be taken or new areas of investigation to be explored by established investigators and on supporting the research programs of the most promising investigators at the beginning of their research careers. Applicants need not be trained specifically in cancer research. Indeed, CPRIT strongly encourages investigators from other fields, including the mathematical, physical, chemical, and engineering sciences, to bring their expertise to bear on the exceptionally challenging problems posed by cancer.
Applicants may request a maximum of $500,000 in total per year for up to three years.
High-Impact/High-Risk Research Awards
RFA Release: February 15, 2011
Application Due Date: May 31, 2011
Award Notification: October 2011
This RFA solicits applications for relatively short-term, high-impact/high-risk projects that are especially innovative in nature, exploring new concepts or new avenues of cancer research. CPRIT encourages applications that seek to apply or develop state-of-the-art technologies, tools, and/or resources for cancer research, including those with potential commercialization opportunities. CPRIT expects outcomes of supported activities to directly and indirectly benefit subsequent cancer research efforts, cancer public health policy, or the continuum of cancer care—from prevention to treatment and cure. To fulfill this vision, applications may address any research topic or issue related to cancer biology, causation, prevention, detection or screening, treatment, or cure.
Applicants may request a total of $200,000 for up to 2 years.
LIMIT ON THE NUMBER OF PROPOSALS: Texas A&M and the Texas A&M Health Science Center are limited to submitting five proposals each. If you are a Texas A&M investigator, click here for information on submitting limited submission proposals. If you are a HSC investigator, contact the Office of Research.
RFA Release: February 15, 2011
Application Due Date: May 31, 2011
Award Notification: October 2011
This RFA solicits applications from institutions to establish or enhance core research facilities (laboratory based or clinical) that will directly support cancer research programs to advance knowledge of the causes, prevention, and/or treatment of cancer.
Applicants may request up to $6M over a maximum of 5 years (see RFA for details) to cover instrumentation, installation, necessary renovation, and operational expenses (see RFA for details).
LIMIT ON THE NUMBER OF PROPOSALS: An institution may submit only one application in response to this funding opportunity. If you are a Texas A&M investigator, click here for information on submitting limited submission proposals. If you are a HSC investigator, contact the Office of Research.
Recruitment of Established Investigators
RFA Release: September 1, 2010
Application Due Date: Continuous
Award Notification: Continuous
Purpose: to attract outstanding senior research faculty with established cancer research programs to academic institutions in Texas.
Recruitment of First-Time, Tenure-Track Faculty Members
RFA Release: September 1, 2010
Application Due Date: Continuous
Award Notification: Continuous
Purpose: to support emerging investigators with the ability to make outstanding contributions to the field of cancer research, promote inquiry into new areas, foster collaboration, and stimulate growth in the field.
RFA Release: September 1, 2010
Application Due Date: Continuous
Award Notification: Continuous
Purpose: to support the recruitment of critically important researchers who are needed to complete existing, excellent teams ("missing links").
RFA Release: September 1, 2010
Application Due Date: Continuous
Award Notification: Continuous
Purpose: to recruit outstanding investigators who are at a relatively early stage in their career to the State of Texas.
Commercialization Programs
Company Commercialization Awards
RFA Release: June 30, 2011
Application Due Date: August 25, 2011
Award Notification: March 30, 2012
To finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships located and headquartered in Texas, or those that are willing to relocate to Texas, with the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award is intended to support companies that will be staffed with a majority of Texas-based employees, including C-level executives.
RFA Release: June 30, 2011
Application Due Date: August 25, 2011
Award Notification: March 30, 2012
To finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will assist early-stage “start-up” companies by providing the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a majority of Texas-based employees. In determining eligibility for this award, CPRIT will evaluate whether applicants have a significant presence in Texas or are willing to relocate to Texas.
RFA Release: June 30, 2011
Application Due Date: August 25, 2011
Award Notification: March 30, 2012
The goal of the Company Relocation Awards is to finance the development of innovative products, services, and infrastructure with significant potential impact on patient care. These investments will provide companies or limited partnerships that are willing to relocate to Texas with the opportunity to further the development of new products for the diagnosis, treatment, or prevention of cancer; to establish infrastructure that is critical to the development of a robust industry; or to fill a treatment or research gap. This award mechanism will support companies that intend to undertake product research and development in Texas with a majority of Texas-based employees.
Texas Life Science Incubator Infrastructure Awards
RFA Release: May 11, 2011
Application Due Date: August 30, 2011
Award Notification: November 2011
The goal of the Texas Life Sciences Incubator Infrastructure Award is the development or enhancement of incubator organizations that will provide valuable programs and services in Texas to enhance the ability to commercialize innovative, new products for the diagnosis, treatment, or prevention of cancer and to establish infrastructure that is critical to the development of a robust life sciences industry in the State. Supported incubator programs should promote a culture that rewards risk-taking and entrepreneurial projects, fosters collaboration and cooperation among different Texas institutions and organizations, and creates an environment of mentoring and shared experience and skills to foster the development of new entrepreneurs. This award is intended to support incubator organizations located in the State (with Texas-based employees) providing incubator services to Texas-based translational research projects and startup companies.
Prevention Awards
- Texans Conquer Cancer Patient Support Services
- Health Promotion, Education and Training for Public Health Care Professional Audiences
- Evidence-Based Primary Prevention, Early Detection, and Survivorship Services
Research Awards
- Individual Investigator Research
- Multi-Investigator Research
- Shared Instrumentation
- High-Impact/High-Risk Research
- Research Training
Commercialization Awards
- Company Recruitment, Relocation and Formation
- Company Commercialization Funding Award
- Company Investment
